1. Nuclear Medicine Department, Cochin Hospital, René Descartes University, Paris, France;
2. Nuclear Medicine Department and
3. Haematology, Santa Maria Nuova Hospital, Istituto Di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy;
4. Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy;
5. Unité d’Hémopathies Lymphoïdes, Hôpitaux Universitaires Henri Mondor, Université Paris Est, Créteil, France;
6. Department of Biostatistics (Lymphoma Academic Research Organisation), Centre Hospitalier Lyon Sud, Pierre Bénite, France;
7. Hématologie Clinique, Hôpital le Bocage, Centre Hospitalier Universitaire Dijon, Dijon, France;
8. Service de Médecine Nucléaire, Centre Georges François Leclerc, Dijon, France;
9. Département d’Hématologie, UMR918, Centre Henri Becquerel, Université de Rouen, Rouen, France;
10. Hospices Civils de Lyon, Service d’Hématologie, Université Claude Bernard Lyon 1, INSERM 1052, Pierre Bénite, France;
11. Haematology Department, Concord Hospital, University of Sydney, Concord, NSW, Australia; and
12. Lymphoma Study Association Imaging, Hôpitaux Universitaires Henri Mondor, Université Paris Est, Créteil, France